Effect of neoadjuvant therapy on breast cancer biomarker profile

BMC Cancer
Laura Rey-VargasSilvia J Serrano-Gomez

Abstract

Breast cancer clinical management requires the assessment of hormone receptors (estrogen (ER) and progesterone receptor (PR)), human epidermal growth factor receptor 2 (HER2) and cellular proliferation index Ki67, by immunohistochemistry (IHC), in order to choose and guide therapy according to tumor biology. Many studies have reported contradictory results regarding changes in the biomarker profile after neoadjuvant therapy (NAT). Given its clinical implications for the disease management, we aimed to analyze changes in ER, PR, HER2, and Ki67 expression in paired core-needle biopsies and surgical samples in breast cancer patients that had either been treated or not with NAT. We included 139 patients with confirmed diagnosis of invasive ductal breast carcinoma from the Colombian National Cancer Institute. Variation in biomarker profile were assessed according to NAT administration (NAT and no-NAT treated cases) and NAT scheme (hormonal, cytotoxic, cytotoxic + trastuzumab, combined). Chi-squared and Wilcoxon signed-rank test were used to identify changes in biomarker status and percentage expression, respectively, in the corresponding groups. We did not find any significant variations in biomarker status or expression values in t...Continue Reading

References

Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Jan 11, 2005·Cancer Letters·Antonio CavaliereEmilio Bucciarelli
Jul 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G Bruce MannMalcolm R Buchanan
Oct 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xiaojiang CuiAdrian V Lee
Jan 18, 2007·Journal of the National Cancer Institute·Mitch DowsettUNKNOWN IMPACT Trialists Group
Apr 9, 2009·Pharmacogenetics and Genomics·Soo-Chin LeeBoon-Cher Goh
Feb 27, 2010·Journal of Surgical Oncology·Stephen V LiuStephen F Sener
Dec 15, 2010·Molecular Oncology·Aleix Prat, Charles M Perou
Mar 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angela Brodie, Gauri Sabnis
Dec 20, 2011·Cancer Treatment Reviews·Pilar ErolesAna Lluch
Oct 30, 2012·Clinical Breast Cancer·Peifeng LiZhe Wang
Sep 10, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V GuarneriP F Conte
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Nov 5, 2013·Pathology, Research and Practice·Yu-Feng YangNing-Fu Peng
Jul 19, 2014·The Breast : Official Journal of the European Society of Mastology·Michael UntchGunter von Minckwitz
Apr 14, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Siew Kuan LimEun Sook Lee
Apr 22, 2015·Nature Reviews. Clinical Oncology·Dimitrios ZardavasMartine Piccart
Jul 25, 2015·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Elena ProvenzanoUNKNOWN Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collabo
Sep 5, 2015·International Journal of Clinical Oncology·Yukie EnomotoYasuo Miyoshi
Oct 21, 2015·Nature Reviews. Clinical Oncology·Michael W SchmittJesse J Salk
Dec 26, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N NiikuraY Tokuda
Feb 10, 2016·Nature Reviews. Clinical Oncology·Frederique Penault-Llorca, Nina Radosevic-Robin
Apr 12, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Renu GahlautAbeer M Shaaban
Mar 5, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J DuffyF Cardoso
Jan 3, 2018·World Journal of Surgical Oncology·Atif Ali HashmiAmir Khan
Jan 25, 2018·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Soomin AhnSo Yeon Park
Jun 13, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter BarryAndrea Sottoriva
Aug 23, 2018·Molecular Oncology·Inga H RyeHege G Russnes
Feb 27, 2019·Breast Cancer Research and Treatment·Tanja IgnatovAtanas Ignatov

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy
dissection

Software Mentioned

R

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.